Skip to content

Dr. L. De Pourcq

Active Private limited companyfounded 2010active for 16 yearsHerentalsebaan 46, 2100 AntwerpKBO/BCE: BE 0827.041.497

Lifetime

15 annual accounts with figures on one time axis
peak of €312,595 in 2011
€216,069▼ 6.2%
lowest -€18,997 in 2020
€121,879▲ 7.8%
peak of €361,075 in 2025
€361,075▲ 51.0%
€208,994▼ 19.7%
Board2 names since 2010
2 directors and 1 other
Documentsfilings and deeds
31-08-202631 days late
2025micro format
Equity from €239,196 to €361,075Debts from €260,332 to €208,994Cash from €110,757 to €42,655

Key points

from the 2025 annual accounts

Equity

€361,075 ▲ 51.0%
€239,0002024€361,0002025

Equity rose in 2025 from €239,196 to €361,075.

Liquidity

13.64 was 5.80 in 2024

Short-term debts fell from €53,462 to €30,437.

Filings

15 annual accounts since 2011
AprilJune31 JulyOctober201520202025

Nine of the last ten came late. The 2024 accounts came in latest, 64 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,816 companies had the same profile as Dr. L. De Pourcq has now. Each dot stands for 45 companies, two years later.

96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,816 companies, not a prediction for Dr. L. De Pourcq. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager
Director
  • 63 sharesdeed of 13-02-2014
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0827041497
appointed as director General meeting of 13-09-2023 · Gazette deed
Capital decrease of €144,000 to €18,600 The capital fell from €162,600 to €18,600, cancelling 63 shares · Gazette deed
Capital increase of €144,000 to €162,600 The capital rose from €18,600 to €162,600, with 63 new shares · Contribution by · General meeting of 27-12-2013 · Gazette deed
All 29 events

Comparable companies

same main activity, similar in size and age
Company
Dr. L. De Pourcq Antwerp €570,069 €216,069 63.3% -
J.L. Jadoul Anesthesist Grobbendonk €551,994 €204,815 92.0% -
DOKTER DEMUYNCK ENDOCRINO - DIABETOLOGIE Boechout €498,702 €204,399 74.2% -
EVRARD B., IMAGERIE MEDICALE Etalle €584,392 €222,525 92.9% -
DR. NOLF BENOIT - GASTRO-ENTEROLOOG Pajottegem €586,969 €207,731 75.8% -
Dr. S. Verstraeten Leuven €564,140 €225,332 98.0% -
CABINET MEDICAL MAGDA GEERINCK Philippeville €601,338 €209,069 94.4% -

These companies have the same main activity as Dr. L. De Pourcq: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €499,000 and €601,000, founded between 2008 and 2011.

Official details

Source: KBO
Status
Active since 24-06-2010Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.190.593.4612100 Antwerp, since 24-06-2010
Financial year end
31 December
Peppol
Reachable since 24-11-2023
Company details

Annual accounts 2025

≈ €400,000estimated
€570,069▲ 14.1%
Filing
Filed on 31-08-2026
Financials

Insights on Dr. L. De Pourcq

Dr. L. De Pourcq files the micro format. That format states no turnover. The gross margin fell from €312,595 in 2011 to €216,069 in 2025.

The balance sheet grew most from 2012 to 2014 through fixed assets.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. L. De Pourcq

What is the company number of Dr. L. De Pourcq?
The company number of Dr. L. De Pourcq is 0827.041.497. The VAT number is the same number with BE in front: BE 0827.041.497.
Where is Dr. L. De Pourcq based?
The registered office is at Herentalsebaan 46, 2100 Antwerp.Company details
What does Dr. L. De Pourcq do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. L. De Pourcq?
Dr. L. De Pourcq is a private limited company (BV).
When was Dr. L. De Pourcq founded?
Dr. L. De Pourcq was founded on 24-06-2010.
Is Dr. L. De Pourcq still active?
Yes, Dr. L. De Pourcq is an active enterprise in the KBO register.
What is the turnover of Dr. L. De Pourcq?
The turnover in financial year 2025 is about €400,000. This figure is estimated from the gross margin of €216,069 and 40 comparable companies (NACE 86220). It probably lies between €340,000 and €530,000.Financials
Is Dr. L. De Pourcq profitable?
In financial year 2025, Dr. L. De Pourcq made a profit of €121,879.
Where can I find the annual accounts of Dr. L. De Pourcq?
Dr. L. De Pourcq filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. L. De Pourcq due?
Dr. L. De Pourcq must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.